SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-132628
Filing Date
2016-11-09
Accepted
2016-11-09 11:09:28
Documents
39
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v451302_10q.htm 10-Q 295421
2 EXHIBIT 31.1 v451302_ex31-1.htm EX-31.1 8273
3 EXHIBIT 31.2 v451302_ex31-2.htm EX-31.2 8207
4 EXHIBIT 32.1 v451302_ex32-1.htm EX-32.1 4179
5 EXHIBIT 32.2 v451302_ex32-2.htm EX-32.2 4099
  Complete submission text file 0001144204-16-132628.txt   1561961

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20160930.xml EX-101.INS 215233
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20160930.xsd EX-101.SCH 22639
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20160930_cal.xml EX-101.CAL 16596
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20160930_def.xml EX-101.DEF 106754
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20160930_lab.xml EX-101.LAB 150288
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20160930_pre.xml EX-101.PRE 125126
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 161983152
SIC: 2836 Biological Products, (No Diagnostic Substances)